Showing results (251-260 of 342) with videos related to

Sort By:
Pageof 35
Skeletal Radiology|May 13, 2014
Skeletal improvement in patients with Gaucher disease type 1: a phase 2 trial of oral eliglustatRavi S Kamath, Elena Lukina, Nora Watman, et al.
British Journal of Haematology|May 30, 2012
Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 yearsCarla E M Hollak, Nadia Belmatoug, J Alexander Cole, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 23, 2009
A validated disease severity scoring system for adults with type 1 Gaucher diseaseNeal J Weinreb, Maria D Cappellini, Timothy M Cox, et al.
International Journal of Molecular Sciences|July 13, 2024
GBA1-Associated Parkinson's Disease Is a Distinct EntityAliaksandr Skrahin, Mia Horowitz, Majdolen Istaiti, et al.
The New England Journal of Medicine|April 23, 2020
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host DiseaseRobert Zeiser, Nikolas von Bubnoff, Jason Butler, et al.
Internal Medicine Journal|October 17, 2018
Revisiting acquired aplastic anaemia: current concepts in diagnosis and managementDanielle B Clucas, Lucy C Fox, Erica M Wood, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 15, 2023
Evaluating the cost-effectiveness of [18F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patientsMichelle Tew, Abby P Douglas, Jeff Szer, et al.
American Journal of Hematology|May 14, 2016
Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher diseaseAri Zimran, Gloria Durán, Atul Mehta, et al.
JAMA Neurology|April 24, 2014
Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotesRoy N Alcalay, Tama Dinur, Timothy Quinn, et al.
Pageof 35